SCHEMBL14809359

SCHEMBL14809359

N=C(Nc1ccccn1)c1cccnc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.54
CYP1A2 P05177 2/20 0.50
HSD17B10 Q99714 2/20 0.50
RAB9A P51151 7/20 0.47
NPC1 O15118 6/20 0.47
PKM P14618 4/20 0.47
GAA P10253 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
NPSR1 Q6W5P4 2/20 0.43
CYP3A4 P08684 1/20 0.43
ATR Q13535 1/20 0.43
LMNA P02545 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10788485 0.84 CYP1A2 (0.61) CYP1A2HSD17B10RAB9ANPC1PKM
SCHEMBL6646471 0.81 RAB9A (0.70) TSHRRAB9ANPC1PKMSMN1; SMN2
SCHEMBL31414959 0.81 RAB9A (0.70) TSHRRAB9ANPC1PKMSMN1; SMN2
SCHEMBL455628 0.78 NAMPT (0.56) RAB9ANPC1PKMGAASMN1; SMN2
SCHEMBL20157091 0.77 KMT2A (0.47) TSHRCYP1A2HSD17B10RAB9ANPC1
SCHEMBL28472490 0.75 RAB9A (0.56) CYP1A2HSD17B10RAB9ANPC1PKM
SCHEMBL28475436 0.75 RAB9A (0.53) CYP1A2HSD17B10RAB9ANPC1PKM
SCHEMBL5780823 0.75 F2 (0.50) CYP1A2HSD17B10RAB9ANPC1PKM
SCHEMBL11304291 0.74 NPC1 (0.62) TSHRCYP1A2HSD17B10RAB9ANPC1
SCHEMBL283481 0.73 HDAC1 (0.60) CYP1A2GAACYP3A4LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2757883-B1 TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS MERCK SHARP & DOHME (US) 2021-01-13 EP disclosed
US-9567333-B2 Triazolopyridyl compounds as aldosterone synthase inhibitors MERCK SHARP & DOHME CORP. (US) 2017-02-14 US disclosed
US-20160039817-A1 TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS MERCK SHARP & DOHME LLC 2016-02-11 US disclosed
US-9193724-B2 Triazolopyridyl compounds as aldosterone synthase inhibitors MERCK SHARP & DOHME CORP. (US) 2015-11-24 US disclosed
US-20140228396-A1 TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS MERCK SHARP & DOHME LLC 2014-08-14 US disclosed
EP-2757883-A1 TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2014-07-30 EP disclosed
WO-2013043520-A1 TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2013-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039817-A1 TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS CYP21A2, HSD11B1, CYP17A1 TSHR 1982/4885CYP1A2 58/4885HSD17B10 77/4885
US-20140228396-A1 TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS CYP21A2, CYP17A1, CYP11B2 TSHR 2025/4885CYP1A2 58/4885HSD17B10 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.